• Return to Headlines

21.8% Return Seen to Date on SmarTrend Biogen Inc Call (BIIB)

By James Quinn

SmarTrend identified an Uptrend for Biogen Inc (NASDAQ:BIIB) on June 12th, 2017 at $262.53. In approximately 3 months, Biogen Inc has returned 21.79% as of today's recent price of $319.74.

In the past 52 weeks, Biogen Inc share prices have been bracketed by a low of $223.02 and a high of $333.65 and are now at $319.74, 43% above that low price. In the last five trading sessions, the 50-day moving average (MA) has climbed 0.2% while the 200-day MA has slid 1%.

Biogen Inc. develops, manufactures, and commercializes therapies, focusing on neurology, oncology, and immunology. The Company products address diseases such as multiple sclerosis, non-hodgkin's lymphoma, rheumatoid arthritis, crohn's disease, and psoriasis.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of Biogen Inc shares.

Log in and add Biogen Inc (BIIB) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights biogen inc

Ticker(s): BIIB